166317-79-9

Upstream product

• 166317-78-8 (1R,3R,4S,8R)-9-<(triisopropylsilyl)oxy>-p-menthol 
• 13834-07-6 (1R,3R,4S,8R)-9-hydroxy-p-menthol 
• 7786-67-6 isopulegol 

Downstream Products

• 166317-80-2 (1R,2S,4S,8R)-2-(3'-oxobutyl)-9-<(triisopropylsilyl)oxy>-p-menthone 
• 946524-47-6 (2S,3R,6S)-3-methyl-6-((R)-1-methyl-2-triisopropylsilanyloxy-ethyl)-2-((E)-3-methylsilanyl-but-2-enyl)-cyclohexan-1-one 
• 946524-59-0 C₁₇H₃₀O₂ 
• 946524-49-8 (1S,2S,3R,6S)-3-methyl-6-((R)-1-methyl-2-triisopropylsilanyloxy-ethyl)-2-((E)-3-methylsilanyl-but-2-enyl)-1-vinyl-cyclohexan-1-ol 
• 946524-57-8 C₂₈H₅₄O₂Si₂ 
• 946524-58-9 C₁₉H₃₆O₂Si 

Relevant academic research and scientific papers

Replacement of the nonperoxidic trioxane oxygen atom of artemisinin by carbon: Total synthesis of (+)-13-carbaartemisinin and related structures

Provided by total synthesis, endoperoxides 17, 19 and 21 underwent intramolecular oxymercuration-demercuration leading respectively to formation of an isomeric tetracycle, (1aS,3S,5aS,6R,8aS,9R,12S)-10-deoxo-13-carbaartemisinin 18, (+)-10-deoxo-13-carbaar

Structure-activity relationships of the antimalarial agent artemisinin. 3. Total synthesis of (+)-13-carbaartemisinin and related tetra- and tricyclic structures

Provided by total synthesis, endoperoxides 18, 20, and 22 underwent intramolecular oxymercuration-demercuration leading respectively to formation of an isomeric tetracycle, (1aS,3S, 5aS,6R,8aS,9R,125)-10-deoxo-13- carbaartemisinin (19), (+)-10-deoxo-13-ca